Smith & Nephew reported $959 million in revenue for the second quarter of 2010, a 4 percent increase from the revenue reported for the second quarter of 2009, according to a company news release.
David Illingworth, Smith & Nephew CEO, attributed the company's profit increase to strong growth in the endoscopy and advanced wound management business. Additionally, the U.S. trauma and European orthopedic businesses also showed significant growth.
Smith & Nephew reported $137 million net profit for the second quarter of 2010, up from $118 million reported for the second quarter of 2009, and $226 million in trading profit.
Trading cash flow is reported as $202 million, an increase from last year's second quarter report, partly attributed to focusing on tighter inventory management.
Read the release on Smith & Nephew 2Q FY 2010 report.
Read other coverage on Smith & Nephew:
- Smith & Nephew Reports 9% Increase in Q1 Revenues
- Data Reinforces Safety, Effectiveness of BIRMINGHAM HIP Resurfacing System
- Smith & Nephew Receives 501k Clearance to Claim 30-Year Performance With VERILAST Technology
David Illingworth, Smith & Nephew CEO, attributed the company's profit increase to strong growth in the endoscopy and advanced wound management business. Additionally, the U.S. trauma and European orthopedic businesses also showed significant growth.
Smith & Nephew reported $137 million net profit for the second quarter of 2010, up from $118 million reported for the second quarter of 2009, and $226 million in trading profit.
Trading cash flow is reported as $202 million, an increase from last year's second quarter report, partly attributed to focusing on tighter inventory management.
Read the release on Smith & Nephew 2Q FY 2010 report.
Read other coverage on Smith & Nephew:
- Smith & Nephew Reports 9% Increase in Q1 Revenues
- Data Reinforces Safety, Effectiveness of BIRMINGHAM HIP Resurfacing System
- Smith & Nephew Receives 501k Clearance to Claim 30-Year Performance With VERILAST Technology